According to a new article in Bloomberg, “the first companies developing medical treatments from psychedelic drugs like LSD, ketamine and the active ingredient in magic mushrooms are gearing up to list on Canadian stock exchanges.” “Mind Medicine Inc., which is undertaking clinical trials of psychedelic-based drugs,” said Kristine Owram for Bloomberg, “intends to list on […]
